BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

15 articles for LB Schenkel

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity.EBI
Amgen
Development of novel azabenzofuran TRPA1 antagonists as in vivo tools.EBI
Amgen
Discovery of potent and highly selective thienopyridine Janus kinase 2 inhibitors.EBI
Amgen
Discovery of triazine-benzimidazoles as selective inhibitors of mTOR.EBI
Amgen
Discovery of a potent, selective, and orally bioavailable pyridinyl-pyrimidine phthalazine aurora kinase inhibitor.EBI
Amgen
Application of a Parallel Synthetic Strategy in the Discovery of Biaryl Acyl Sulfonamides as Efficient and Selective NaV1.7 Inhibitors.EBI
Amgen
Discovery of a biarylamide series of potent, state-dependent NaEBI
Amgen
PARP-1 DEGRADATION AGENT AND USE THEREOFBDB
Xizang Haisco Pharmaceutical Co.
Dizocilpine derivatives as peripheral NMDA receptor antagonistsBDB
Institut National De La Sante Et De La Recherche Medicale (Inserm
Methods of inhibiting kinasesBDB
Insilico Medicine Ip
1-[2-(aminomethyl)benzyl]-2-thioxo-1,2,3,5-tetrahydro-4H-pyrrolo[3,2-d]pyrimidin-4-ones as inhibitors of myeloperoxidaseBDB
Astrazeneca
Pteridine dione monocarboxylate transporter inhibitorsBDB
The Scripps Research Institute
Bis-pyridazine compounds and their use in treating cancerBDB
Cancer Research Technology
Compounds as indoleamine 2,3-dioxygenase inhibitorsBDB
Merck Sharp & Dohme